Mohawk Industries’ stock rallies as flooring-products maker draws upgrade on boosted profit view

Date:

July 26, 2024

Mohawk Industries Inc.’s stock jumped 16% on Friday after the maker of flooring products said it would beat analyst estimates for its third quarter and revealed plans to cut more costs, and after drawing an upgrade to buy from hold from BofA Securities.

Source link

Recall of Boar's Head deli meats announced during investigation of listeria outbreak

'Awfully weird': Trump 'absolutely' regretting picking JD Vance

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Mohawk Industries’ stock rallies as flooring-products maker draws upgrade on boosted profit view

Recent posts

GE Aerospace’s stock jumps after a big profit beat, as commercial orders soared

Disney taps Morgan Stanley’s Gorman to oversee selection of Bob Iger’s successor

Natural-gas prices dropped 11% this week. Beryl may fuel further losses.

Norfolk Southern got more efficient in Q2 despite derailment settlement, shareholder fight

Commodity markets fear a repeat of China’s 2015 economic slowdown

Home builders, flooring companies and pool maker stocks rally as CPI data boosts rate-cut hopes

Nvidia’s bonds in demand heading into earnings, as investors eye companies expected to benefit from AI spending

Want a refund for your delayed or cancelled flight after the CrowdStrike outage? You can get it — here’s the trick.

Adobe sued by U.S. regulators for making it too difficult to cancel subscriptions

Bond king Jeffrey Gundlach still sees a U.S. recession coming. Here’s when.

Paramount to lay off staff, follows WBD in taking big charge on cable business

What’s next for bond markets after a week of wild volatility

Tommy Hilfiger and Calvin Klein parent PVH Corp. raises profit outlook despite ‘continued tough macroeconomic backdrop’

High stakes for investors as Fed tries curing inflation without causing a recession

Starbucks reports worse-than-expected sales but says cost controls are helping

Related articles

Zenas BioPharma sets price range for $200 million initial public offering

Fed’s Goolsbee says trend of economic data justifies multiple Fed rate cuts, starting soon

WK Kellogg is upbeat about going it alone as CEO says ‘don’t sleep on our core brands’

After its August selloff, the U.S. dollar may face more downside risk ahead

The floodgates on the IPO market are unlikely to open before yearend

Eli Lilly’s weekly insulin intensifies race with Novo Nordisk

Kamala Harris backs smaller rise in capital-gains taxes than proposed by Biden

Core & Main’s stock drops 13% as earnings and revenue fall short

Company

Follow us